Test a drug idea to activate fat that burns energy
Treatments studied
Part of Hormones & metabolism clinical trials.
This Phase 2 study tests whether a medication approach can activate “beige” fat, which may help the body burn more energy. It mainly looks for people with higher body weight and prediabetes who are not on diabetes medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) is between 27 and 45
- You have prediabetes, such as A1c 5.7 to 6.4
- Your prediabetes is due to impaired fasting glucose or impaired glucose tolerance
- You do not have diabetes
- You are not taking diabetes medications regularly
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how exercise training affects tiny particles released by muscles and fat cells that help the body communicate. You would do resistance exercise, and researchers will study these particles to see how they might improve metabolism and reduce diabetes risk.
This study looks at whether mirabegron and tadalafil can improve blood sugar control in people with prediabetes. It may help determine if these medicines can slow the move from prediabetes toward diabetes.
This trial tests a combination of two medicines, alpha-lipoic acid (an antioxidant) and mirabegron (a drug for bladder issues), to see if they help people with obesity lose weight and improve metabolism. You would receive the treatment for a period of time while researchers monitor your progress.
This study tests an investigational drug called GS-4571 in healthy people, people with obesity, and people with type 2 diabetes. It aims to see how the drug affects the body and whether it might help with weight and blood sugar control.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This study tests how different amounts of the study medicine PF-08642534 are tolerated and how they work in the body of people with obesity. It aims to find a safe dose for future studies.
Hear when a new Prediabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.